Spots Global Cancer Trial Database for Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory
Official Title: Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory Among Female Cancer Patients
Study ID: NCT04630327
Study Description
Brief Summary: Depression and anxiety in female patients with cancer are serious comorbidities that affect the quality of life for patients and their survival rates as they have poorer health outcomes. This validation study is a part of the study on the prevalence of depression and anxiety among breast cancer patients. This study aims to investigate the validity of the Kazakh and Russian versions of the Beck Depression Inventory (BDI-II) and Beck Anxiety Inventory (BAI) among female cancer patients in Almaty, Kazakhstan.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Kazakh Scientific Research Institute of Oncology and Radiology, Almaty, , Kazakhstan
Almaty Oncology Center, Almaty, , Kazakhstan
Contact Details
Name: Botagoz Turdaliyeva, Professor
Affiliation: Kazakh Medical University of Continuing Education
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
